ScienceTechyNews: Biomarker may predict if immunotherapy is right choice for colorectal cancer patients

Foundational research could help metastatic colorectal cancer patients decide whether to choose immunotherapy or chemotherapy as a first treatment option. 'Immunotherapy is the hot thing, but sometimes traditional chemotherapy can be better. Our study suggests tumor genomics could help doctors decide what kind of treatment will benefit each patient most. Taking this kind of personalized medicine approach, we will be able to provide patients with options that yield better outcomes and are more cost-effective.'

by